Global In-Vitro Toxicology Testing Market Growth, Trends & Forecasts (2017 - 2022)

The Global market for In-Vitro Toxicology testing market has been estimated to be USD 10.8 billion in 2014 and it is projected to reach USD 19 billion by the end of 2020 at a CAGR of 9.8% during the forecast period from 2014 to 2021. Predictive in-vitro toxicology is the new cutting edge in biopharmaceutical research. It is considered one of the most significant steps in drug discovery. Predictive in-vitro toxicology will improve the quality and quantity of drugs entering clinical studies. It improves the safety and efficiency of new compounds and allows compounds to be arranged early in the development process. Earlier and more lucrative identification of potential mechanisms that cause adverse drug reactions have significant potential for improving consequences in drug discovery.

There are different industries that require toxicity testing of their products. On the basis of end-users, the market is segmented into pharmaceutical industry, cosmetics and household products, chemicals industry, and the food and beverages industry. Pharmaceutical industry has the largest market share. This is attributed to the increased adoption of in vitro methods in the detection of toxic effects to curb drug development costs and government initiatives such as AXLR8 program that was initiated by the European Union. Cosmetics industry is expected to be the fastest growing industry in coming years because of government support and amendment of European Union?s Cosmetics Directive that has set forth ban on the use of animals in testing for any toxic effects of beauty products.

Rapid technological advances, huge opposition to animal testing and advances in toxicity testing protocols are the major driving factors for the growth of the In-Vitro Toxicology testing market. However, Predictive ability of the tests, stringent regulatory framework and the inability of in-vitro models to detect certain anomalies are the major challenges faced by the market.

The market for in-vitro toxicology testing is segmented on basis of Technology, Methods and Applications. Technology segment is sub-divided into High Throughput Screening, Molecular Imaging, Cell Culture, Genomics, Toxicogenomics, Proteomics and Metablolomics. The methods involved in in-vitro testing are Cell Assay based, Biochemical Assay based, In Silico based and Ex vivo based methods. The application segment is further categorized into acute systemic toxicity, Dermal Toxicity, Ocular Toxicity pharmacokinetics & metabolism, Organ-Specific Toxicity, Reproductive/Developmental Toxicity and others.

Based on geography the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, Europe is the largest market for In-Vitro Toxicology testing owing to high prevalence of cosmetic product testing and government support, followed by North America. APAC is the fastest growing segment of the market. The emerging countries in Asia such as China and India will register moderately high growth rates compared to previous years because of low development costs and raise in investments.

Many players in this market are trying to expand their product portfolio in order to top the global market. While few companies are entering into the market by acquisitions, top companies are expanding their growth in this market by acquiring other companies. The dominant players in this market are Agilent Technologies, Alere, Inc., Bio-Rad, Sigma Aldrich, Catalent Pharma Solutions, Charles River Laboratories, Covance, Cyprotex, Eurofins Scientific, Inc., GE Healthcare, Thermo Fisher Scientific and Quest Diagnostics.

Key Deliverables in the Study:

Market analysis for the Global In-Vitro Toxicology testing Market, with region specific assessments and competition analysis on global and regional scales
Market definition along with the identification of key drivers and restraints
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global In-Vitro Toxicology testing Market on both global and regional scales
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

1. Introduction

1.1 Report Description

1.2 Research Methodology

2. Key Findings

3. Executive Summary

4. Market Dynamics

4.1 Porters Five Force Analysis

4.2 Market Drivers

4.2.1 Increase in the opposition to animal testing in these procedures

4.2.2 Rapid advances in technologies boosting the market growth

4.2.3 Advances in toxicity testing protocols

4.3 Market Restraints

4.3.1 Predictive ability of these tests hinder the growth of the market

4.3.2 In vitro models not being able to detect certain specific anamolies

4.3.3 Stringent regulatory framework

5. Global Market Segmentation

5.1 By End user

5.1.1 Pharmaceuticals

5.1.2 Food Industry

5.1.3 Chemicals Industry

5.1.4 Cosmetics

5.1.5 Diagnostics

5.1.6 Others

5.2 By Technology

5.2.1 High Throughput Screening

5.2.2 Molecular Imaging

5.2.3 Cell Culture

5.2.4 Genomics

5.2.5 Toxicogenomics

5.2.6 Proteomics

5.2.7 Metablolomics

5.2.8 Others

5.3 By Method

5.3.1 Cell Assay based

5.3.2 Biochemical Assay based

5.3.3 In Silico based

5.3.4 Ex vivo based methods

5.3.5 Others

5.4 By Geography

5.4.1 North America US Canada Mexico

5.4.2 Europe UK Germany France Spain Italy Rest of Europe

5.4.3 Asia Pacific China Japan India South Korea Rest of Asia Pacific

5.4.4 Rest of the World

6. Competitive Landscape

6.1 Mergers & Acquisitions

6.2 Agreements, Collaborations & Partnerships

6.3 New Product Launches

6.4 Recommendations to new market players

7. Company Profiles

7.1 Bio Rad Laboratories

7.2 Accelrys

7.3 Agile Technologies

7.4 Charles River Laboratories

7.5 Covance

7.6 GE Healthcare

7.7 Life Technologies

7.8 Quest Diagnostics

8. Appendix

8.1 Abbreviations

8.2 Sources

8.3 Bibliography

8.4 Disclaimer

Content are not available

Choose License Type